GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (FRA:K3P) » Definitions » Price-to-Funds-From-Operations

Kiadis Pharma NV (FRA:K3P) Price-to-Funds-From-Operations : (As of May. 25, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Kiadis Pharma NV Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Kiadis Pharma NV (FRA:K3P) Business Description

Industry
Traded in Other Exchanges
N/A
Address
Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP
Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.